Abstract

AbstractThe purpose of this work was to study the antimicrobial activity of a new medication “FarGALS” and to determine the prospects of its clinical application to treat nosocomial infections. It was established that “FarGALS” possessed pronounced antimicrobial activity against a wide spectrum of pathogenic microorganisms, such as Gram-positive, Gram-negative, nonspore-forming and spore-forming bacteria, as well as Candida spp. and H. pylori. It has been concluded that the given medication can be used as an antimicrobial agent in the treatment and prevention of various purulent and inflammatory processes, mycosis and other infectious diseases.KeywordsFarGALSAntimicrobial activityPathogenic microorganismsAntisepticWound healing remedies

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.